Cardinal Health, Inc.
CAH Healthcare Medical Distribution
Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025. In the quarter to June 2026, revenue grew 5.84%, EPS grew 68.3%, free cash flow grew 10.9% and total debt rose 4.21%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
Follow CAH
Cardinal Health, Inc. (CAH) Total debt
Cardinal Health, Inc.'s total debt at the end of fiscal 2026 was $8.9B, unchanged from fiscal 2025. Over the past ten years it has ranged from $4.7B (fiscal 2023) to $10.4B (fiscal 2017); the current reading is higher than 83% of that period. Cardinal Health, Inc. ranks 3rd of 11 Medical Distribution companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2026 | $8.9B | 4.21% |
| FY2025 | $8.5B | 67.46% |
| FY2024 | $5.1B | 8.32% |
| FY2023 | $4.7B | (11.55%) |
| FY2022 | $5.3B | (14.77%) |
| FY2021 | $6.2B | (7.96%) |
| FY2020 | $6.8B | (15.64%) |
| FY2019 | $8.0B | (10.90%) |
| FY2018 | $9.0B | (13.29%) |
| FY2017 | $10.4B | 87.67% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $8.9B | (0.34%) |
| Mar 2026 | $8.9B | (1.23%) |
| Dec 2025 | $9.0B | (0.06%) |
| Sep 2025 | $9.0B | 5.92% |
| 42 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| MCK McKesson Corporation compare | $14.8B |
| COR Cencora, Inc. compare | $11.7B |
| CAH Cardinal Health, Inc. | $8.9B |
| HSIC Henry Schein, Inc. compare | $2.4B |
| ACH Accendra Health, Inc. compare | $1.7B |
| FOCL FocalTherics compare | $40.1M |
| COSM Cosmos Health Inc. compare | $11.8M |
| AHG Akso Health Group Sponsored ADR compare | $4.6M |
| HKPD Cellyan Biotechnology Co., Ltd compare | $943.3K |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on CAH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement